Xu L - Search Results

1

Homozygous deletions and loss of expression of the CDKN2 gene occur frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumors.

Lydiatt WM, Murty VV, Davidson BJ, Xu L, Dyomina K, Sacks PG, Schantz SP, Chaganti RS. Lydiatt WM, et al. Among authors: xu l. Genes Chromosomes Cancer. 1995 Jun;13(2):94-8. doi: 10.1002/gcc.2870130204. Genes Chromosomes Cancer. 1995. PMID: 7542912

2

Consistent chromosomal losses in head and neck squamous cell carcinoma cell lines.

Sreekantaiah C, Rao PH, Xu L, Sacks PG, Schantz SP, Chaganti RS. Sreekantaiah C, et al. Among authors: xu l. Genes Chromosomes Cancer. 1994 Sep;11(1):29-39. doi: 10.1002/gcc.2870110106. Genes Chromosomes Cancer. 1994. PMID: 7529044

3

TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines.

Xu L, Davidson BJ, Murty VV, Li RG, Sacks PG, Garin-Chesa P, Schantz SP, Chaganti RS. Xu L, et al. Int J Cancer. 1994 Nov 1;59(3):383-7. doi: 10.1002/ijc.2910590316. Int J Cancer. 1994. PMID: 7927946

4

Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations.

Xu L, Chen YT, Huvos AG, Zlotolow IM, Rettig WJ, Old LJ, Garin-Chesa P. Xu L, et al. Diagn Mol Pathol. 1994 Jun;3(2):83-92. doi: 10.1097/00019606-199406000-00004. Diagn Mol Pathol. 1994. PMID: 8061893

5

Microsatellite instability at selected tetranucleotide repeats is associated with p53 mutations in non-small cell lung cancer.

Ahrendt SA, Decker PA, Doffek K, Wang B, Xu L, Demeure MJ, Jen J, Sidransky D. Ahrendt SA, et al. Among authors: xu l. Cancer Res. 2000 May 1;60(9):2488-91. Cancer Res. 2000. PMID: 10811129

6

Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells.

Xu L, Xie K, Mukaida N, Matsushima K, Fidler IJ. Xu L, et al. Cancer Res. 1999 Nov 15;59(22):5822-9. Cancer Res. 1999. PMID: 10582705

7

Frameshift and nonsense p53 mutations in squamous-cell carcinoma of head and neck - non-reactivity with 3 anti-p53 monoclonal-antibodies.

Chen Y, Xu L, Massey L, Zlotolow I, Huvos A, Garinchesa P, Old L. Chen Y, et al. Among authors: xu l. Int J Oncol. 1994 Mar;4(3):609-14. doi: 10.3892/ijo.4.3.609. Int J Oncol. 1994. PMID: 21566966

8

Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells.

Xu L, Fidler IJ. Xu L, et al. Cancer Res. 2000 Aug 15;60(16):4610-6. Cancer Res. 2000. PMID: 10969814

9

Microsatellite instability at AAAG repeat sequences in respiratory tract cancers.

Xu L, Chow J, Bonacum J, Eisenberger C, Ahrendt SA, Spafford M, Wu L, Lee SM, Piantadosi S, Tockman MS, Sidransky D, Jen J. Xu L, et al. Int J Cancer. 2001 Jan 15;91(2):200-4. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1031>3.0.co;2-0. Int J Cancer. 2001. PMID: 11146445

10

ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.

Hazawa M, Lin DC, Handral H, Xu L, Chen Y, Jiang YY, Mayakonda A, Ding LW, Meng X, Sharma A, Samuel S, Movahednia MM, Wong RW, Yang H, Tong C, Koeffler HP. Hazawa M, et al. Among authors: xu l. Oncogene. 2017 Apr 20;36(16):2243-2254. doi: 10.1038/onc.2016.377. Epub 2016 Nov 7. Oncogene. 2017. PMID: 27819679 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,913 results

Search Page

Filters